Summary:
Click image to enlarge
Learn more about a clinical trial of a study drug for people who are living with heart failure with reduced ejection fraction, or HFrEF. Also called systolic heart failure, HFrEF is a type of cardiac dysfunction where the heart is too weak to pump enough blood around the body.
You may be able to join the POWER-HF study if you or your loved one:
- Are between 30 to 85 years old
- Have been diagnosed with symptomatic heart failure in at least the past 90 days
- Have been on the same medical therapy for heart failure for at least 4 weeks
- Other requirements need to be met to join the POWER-HF study.
Qualified Participants May Receive:
Participants in the study will receive at no cost:
- Treatment with the study drug or placebo
- Close care and oversight by the study doctor throughout the study